Explore how the APD NGS Panel enables comprehensive genetic analysis for Alzheimer’s, Parkinson’s disease, and dementia through a single NGS-based test. The panel covers 139 clinically relevant genes and supports detection of SNVs, InDels, and CNVs from a blood sample, helping laboratories streamline genetic testing and clinical interpretation. Read the complete blog to learn more about the APD NGS Panel, its features, applications, and role in neurodegenerative disease testing.